Skip to main content
All

Please Join Us for a Panel Discussion: Venture Philanthropy, Strategic Impact VC, and Blended Finance Strategies to Advance Product Development

Monday, January 12, 2026
3-4 p.m. PT

Arnold & Porter's San Francisco Office
Three Embarcadero Center
10th Floor
San Francisco, CA 94111

*Cocktails to follow at Harlan Records, 18 Harlan Place @ Grant Avenue

Arnold & Porter Presentation
Register

In this increasingly competitive funding environment, alternative funding sources beyond traditional capital are more important than ever. Please join us for a lively discussion of how venture philanthropy strategies can be used to advance product development at all stages, from early-stage ideas, to proof of concept, to the clinic, and beyond. Industry leaders from the nonprofit and legal sectors will lead this session aimed at biotechs, newcos and charitable funders of research. Discover the range of tools available across the full spectrum of venture philanthropy, from charitable grants to commercial investments alongside venture funders, to advance your assets. We’ll discuss case studies of what has worked for others, and will identify the legal requirements and practical considerations at each step in the process. The session aims to leave you with new ideas for practical frameworks for structuring deals that combine philanthropic and commercial capital.

Join us for cocktails at Harlan Records following the program!

Meet the Speakers

Kevin Marks
Chief Legal Officer, Parker Institute for Cancer Immunotherapy
Alice Pomponio
Vice President, Innovation & Impact Investing / Managing Director, BrightEdge (a Philanthropic Impact Fund of the American Cancer Society)
Mark Veich
Chief Organizational Advancement Officer, Parker Institute for Cancer Immunotherapy
Amy Ryan
Partner
Arnold & Porter
James P. Joseph
Partner
Arnold & Porter